Reappointment of Dr. Dinesh Kumar Chirla.
RAINBOW · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Rainbow Children's Medicare's Board approved audited financial results for Q4 and FY2026 with an unmodified opinion from S.R. Batliboi & Associates. The Board recommended a final dividend of ₹3.5 per share (35% payout) for FY2026, subject to shareholder approval at the July 29, 2026 AGM. Record date is July 21, 2026. Key appointments include the reappointment of Dr. Dinesh Kumar Chirla as Whole Time Director for 5 years (Aug 2026 to Aug 2031), along with reappointments of Dr. Ramesh Kancharla (Chairman & MD) and two Independent Directors (Mr. Santanu Mukherjee and Ms. Sundari R. Pisupati). Dr. Chirla is a promoter and has been on the Board since 2005 with expertise in neonatology and paediatric intensive care. Cost auditors M/s. Lavanya & Associates LLP were also reappointed for FY2026-27.
Reappointment of key directors and promoters signals management continuity and stability, which is positive for shareholders. The dividend recommendation and strong audit opinion reinforce financial health.